The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIq-ai Ltd Share News (IQAI)

Share Price Information for Iq-ai Ltd (IQAI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.55
Bid: 1.50
Ask: 1.60
Change: -0.10 (-6.06%)
Spread: 0.10 (6.667%)
Open: 1.65
High: 1.65
Low: 1.55
Prev. Close: 1.65
IQAI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Impellam's first quarter beats pre-virus levels

Thu, 28th Apr 2022 19:25

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

Impellam Group PLC - Luton, England-based recruiter - For the first quarter ended April 1, revenue grows 17% year-on-year to GBP612.7 million, and is also 12% above pre-pandemic levels, leading to earnings before interest, tax, depreciation and amortisation rising 68% to GBP10.1 million from a year prior, and 60% above pre-pandemic levels.

----------

Resolute Mining Ltd - Perth-based gold miner in Africa - For the three months ended March 31, gold poured rises 2% at 81,770 ounces from 79,816 ounces the same period a year before, leading to a 17% increase in gold sales to 88,773 ounces from 75,636 ounces, at an average realised price of USD1,876 per ounce from USD1,749. The improved gold production is from better performances from the Syama Oxide operation in Mali as well as Mako in Senegal.

----------

Aptitude Software Group PLC - London-based finance transformation and automation software - For the year to date, continues to make good operational progress, with new business across its product suite in all regions throughout the first months of the year, including a multi-year eSuite contract win with a global broadcaster, leading to confidence that Aptitude will meet management expectations in performance for 2022.

----------

Libertine Holdings PLC - Sheffield, England-based technology for power generation from renewable fuels - For the year ended March 31, the company delivers GBP3 million in commercial and grant income contract milestones, and has completed the internal combustion systems design and manufacture for the MAHLE Powertrain, which is ready for planned combustion testing from the first quarter of its current financial year. As at March 31, has GBP6.7 million in cash reserves.

----------

C4X Discovery Holdings PLC - Manchester-based developer of drug discoveries - For the six months ended January 31, pretax loss widens to GBP5.5 million from GBP4.5 million the same period a year before, on higher R&D and administrative expenses, while generating GBP66,000 in revenue.

----------

PPHE Hotel Group Ltd - Amsterdam-based hotel owner and operator - For the first quarter ended March 31, total revenue rises sharply to GBP32.0 million from GBP5.3 million the same period a year before, as demand for international travel and hotels grow. However, the figure remains 49% below pre-virus levels, which stands at GBP62.5 million for the three months ended March 31, 2019. Revenue per available room rises to GBP124.1 from GBP72.9 a year prior, as occupancy climbs to 34.2% from 7.1%. Looking ahead, the momentum achieved by PPHE in the first quarter has continued into the second quarter.

----------

Merit Group PLC - business intelligence, media and technology resourcing - For the year ending March 31, adjusted earnings before interest, tax, depreciation and amortisation rises to GBP2.8 million, ahead of market expectations of GBP2.0 million, as revenue increases 10% year-on-year. "The group's recovery and improved financial performance will allow us to concentrate on our strategic goal of building a strong growth company focused on technology enabled business intelligence," says Chief Executive Officer David Beck.

----------

Nexus Infrastructure PLC - Essex, England-based infrastructure services provider - For the six months ended March 31, revenue is expected to grow 25% to GBP80 million from GBP63.9 million, as the total order book as at March 31 stands at GBP306.8 million, a 1.7% rise from GBP301.6 million. Revenue growth is fostered by strong performances from TriConnex and sharp growth from eSmart Networks.

----------

Smoove PLC - Oxfordshire, England-based online platforms for conveyancing and financial intermediary markets - For the year ended March 31, revenue rises 12% to GBP19 million from GBP17 million the year before, as conveyancing completions in the period grows 10% to 37,009, while instructions rise 22% to 67,156. Revenue growth is driven by strong growth in the broker channel and increased demand through a bounce back from Covid-19. Looking ahead, the company continues to see strong trading demand for its flagship eConveyancer brand.

----------

Vianet Group PLC - Stockton-on-Tees, England provider of retail sales and volume monitoring systems - Through a strong recovery in the second half, for the year ended March 31, revenue is expected to to rise 55% to GBP13.0 million from GBP8.4 million the prior year, on new contract wins and device sales. As a result, operating profit is set to be GBP2.2 million, swinging from a loss of GBP700,000.

----------

Kerry Group PLC - Tralee, Ireland-based nutrition products - For the three months ended arch 31, group volumes grow 5.6%, and 6.3% on a like-for-like basis, with growth in Taste & Nutrition and Dairy Ireland. Group revenue grows 8.1% year-on-year, and for 2022 as a whole, expects to achieve adjusted earnings per share rise between 5% and 9% on a constant currency basis.

----------

Mkango Resources Ltd - Vancouver-based explorer for rare earth elements - For 2021, pretax loss widens to USD9.7 million from USD4.1 million the year before, on a sharp rise in administrative costs and mineral project expenditures. Looking ahead, the feasibility study for Songwe is expected to be completed in the second quarter of 2022, while studies for the Pulawy rare earth separation plant in Poland is underway.

----------

Glenveagh Properties PLC - Dublin-based housebuilder - For 2022 to date, company has a total order book of 2,160 units across Suburban and Urban segments, and is on-track to deliver 1,400 Suburban homes in 2022 with 80% sold, signed or received. Looking ahead, the company intends to launch a further EUR75 million buyback programme. "The growth in the Suburban segment, allied with the Partnership's business which is set to materially deliver from 2024, means the group expects to see continued growth in 2024 and beyond," the company states.

----------

IQ-AI Ltd - Jersey-based medical services firm - For 2021, pretax loss narrows to GBP501,058 from GBP717,534 the year before, as revenue more than doubles to a record figure of GBP521,069 from GBP255,314, through the securing of several new patients, and the achievement of new product development milestones.

----------

Creo Medical Group PLC - Chepstow, Wales-based medical device company - For 2021, expects revenue to be at least GBP25 million, more than doubling from GBP9.4 million the year before. This momentum carries on into the first quarter of 2022, with revenue being strong and supported by the reopening of markets post Covid-19 and the resultant backlog of demand for elective procedures and adoption of Creo Speedboat Inject device.

----------

Aseana Properties Ltd - property developer in Malaysia and Vietnam - For the 2021, pretax loss narrows to USD4.8 million from USD9.1 million loss in 2020. Says loss was largely due to the finance cost incurred in relation to RuMa Hotel & Residences and the Sandakan hotel asset and the Harbour Mall in Sandakan, in the Malaysian state of Sabah.

----------

By Dayo Laniyan; dayolaniyan@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
10 May 2024 15:14

IQ-AI subsidiary gets rare paediatric disease designation FDA

(Alliance News) - IQ-AI Ltd on Friday said its subsidiary, Imaging Biometrics LLC, has been granted rare paediatric disease designation by the US Food & Drug Administration for its lead drug candidate, IB-003, or gallium maltolate for the treatment of ATRT.

Read more
2 May 2024 15:45

EARNINGS AND TRADING: Trident Royalties swings to profit

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
22 Feb 2024 14:02

IN BRIEF: IQ-AI shares sink on discounted placing fundraise

IQ-AI Ltd - Medical services firm and parent company of Wisconsin-based healthcare imaging software firm Imaging Biometrics LLC - Announces placing to raise GBP300,000 gross proceeds via the issue of 20.0 million new shares at a price of 1.5p each. The issue price represents a discount of 32% to the company's Wednesday closing price of 2.2p. The placing includes a broker option for existing shareholders for up to 6.7 million new shares, which would raise an additional GBP100,000. Admission of the new placing and broker option shares is expected to occur on or around March 1.

Read more
9 Feb 2024 13:38

IQ-AI subsidiary asked by FDA to resubmit and modify application

(Alliance News) - IQ-AI Ltd on Friday said its subsidiary Imaging Biometric LLC will modify and resubmit its application to the US Food & Drug Administration.

Read more
2 Feb 2024 08:56

IN BRIEF: IQ-AI celebrates USD100,000 grant for subsidiary

IQ-AI Ltd - St Helier, Jersey-based medical services firm - Says that Imaging Biometrics LLC, a wholly-owned subsidiary of IQ-AI, has been given a USD100,000 grant by the Musella Foundation For Brain Tumor Research & Information Inc. Explains that the grant will help to support the launch of an intermediate group expanded access programme, which is focused on giving brain tumour patients access to oral gallium maltolate, outside of an ongoing Phase One clinical trial at the Medical College of Wisconsin. The grant will be used to facilitate the expanded access programme, including writing and submitting the study protocol, patient screening and on-boarding.

Read more
10 Jan 2024 11:48

IQ-AI falls after subsidiary notes launch of treatment access scheme

(Alliance News) - IQ-AI Ltd shares fell on Wednesday, after it said its subsidiary Imaging Biometrics LLC is launching an intermediate population cohort expanded access programme for oral gallium maltolate.

Read more
19 Dec 2023 17:00

IQ-AI firm gets US FDA fast-track status for oral gallium maltolate

(Alliance News) - IQ-AI Ltd on Tuesday said the US Food & Drug Administration has granted 'fast-track" designation for oral gallium maltolate, which is its subsidiary Imaging Biometrics LLC's therapeutic for the treatment of adult patients with relapsed or refractory glioblastoma.

Read more
5 Dec 2023 11:49

IQ-AI stock rises on positive interim results from glioblastoma trial

(Alliance News) - IQ-AI Ltd on Tuesday reported positive results from Phase 1 of an on-going study for its investigational monotherapy oral gallium maltolate.

Read more
8 Nov 2023 12:04

IQ-AI says Imaging Biometrics submits paediatric rare disease request

(Alliance News) - IQ-AI Ltd on Wednesday said its wholly-owned subsidiary Imaging Biometrics LLC has submitted a paediatric rare disease request to the US Food & Drug Administration for its gallium maltolate therapy.

Read more
18 Oct 2023 17:11

IN BRIEF: IQ-AI subsidiary "central" to "landmark" brain cancer study

IQ-AI Ltd - St Helier, Jersey-based medical services firm focused on cancer treatment - Notes its wholly-owned subsidiary, Imaging Biometrics LLC (IB), has announced the results of a "landmark" study. Says the study represents the first large-scale characterization of the invasive tumour margins of high-grade glioma using multi-regional genomic/transcriptomic sequencing with spatially matched MRI measurements in glioma. High-grade glioma is a deadly brain cancer. Explains that Imaging Biometrics' IB Neuro's dynamic susceptibility contrast magnetic resonance imaging software was central to the study.

Read more
9 Oct 2023 12:09

IN BRIEF: IQ-AI subsidiary wins orphan drug designation from US FDA

IQ-AI Ltd - St Helier, Jersey-based medical services firm focused on cancer treatment - Wholly-owned subsidiary Imaging Biometrics LLC is granted an orphan drug designation from the US Food & Drug Administration for gallium maltolate for the treatment of atypical teratoid rhabdoid tumour. Notes this is the second orphan designation granted to gallium maltolate this year.

Read more
8 Sep 2023 10:25

IQ-AI notes vindication of subsidiary's reduced gadolinium approach

(Alliance News) - IQ-AI Ltd on Friday noted that studies by its subsidiary Imaging Biometrics LLC validated the dosing approach of Imaging's MRI-focused IB Neuro.

Read more
18 Aug 2023 12:17

IQ-AI shares jump on subsidiary's GE Healthcare deal

(Alliance News) - IQ-AI Ltd on Friday said its wholly-owned subsidiary Imaging Biometrics LLC has signed a deal with GE HealthCare Technologies Inc.

Read more
17 Aug 2023 11:21

IQ-AI interim loss narrows amid higher revenue, lower expenses

(Alliance News) - IQ-AI Ltd on Thursday announced a slightly lower loss for the six months to June 30, as revenue was up and administrative expenses were lower.

Read more
19 Jul 2023 10:45

IN BRIEF: IQ-AI subsidiary's app adopted by US medical college

IQ-AI Ltd - Jersey-based medical services firm focused on cancer treatment - Says subsidiary Imaging Biometrics LLC's handheld application IB Nimble has been adopted by the Medical College of Wisconsin's Orthopedic Department for use in bone metastases treatment. IB Nimble's designer, Joseph Bovi, is professor of radiation oncology & neurosurgery at MCW. The application was originally designed to help treat brain metastases. IQ-AI says it "provides real-time collaboration amongst multi-disciplinary teams" to "provide optimised treatments faster". Josh McComack, Imaging Biometrics' director of software engineering, says the new installation "demonstrates that IB Nimble is ready for widespread deployment."

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.